Investors

Click here for our Investor’s Presentation.

Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product

Read More »

Neutrisci Receives Additional Order for Japanese Market

Read More »

NeutriSci Announces New State-of-the-Art Production and Research Facility in Las Vegas, Nevada, USA

Read More »

NeutriSci: Harmonized Code Approval Received by Tabletz LLC., in Japan

Read More »

NeutriSci Receieves Multi-Million Dollar Order for Japanese Market

Read More »

Disclaimer:

All information is provided “as is” for informational purposes only and is not intended for trading purposes or advice. Neither NuetriSci nor any independent providers are liable for any errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Subscribe to Our Newsletter

By subscribing to our Newsletter you will receive NeutriSci’s press releases and news as they develop by email. We do not send direct mail, customized online advertising, and we do not share your personal information. We respect your privacy.

Disclaimer

NeutriSci International maintains the investor relations section of this internet site as an informational service and for the readers.

This site is not intended to supplement or substitute for the legal disclosure for the Corporation or the prospectus disclosure related to the public offering of any of its securities.